Agilent AriaMx; Douglas Scientific IntelliQube; QIAGEN Rotor-Gene Q; Stratagene MxP ® Stratagene MxP ® Stratagene Mx Agilent Stratagene MxP Real-Time PCR Model QPCR. $2, Free shipping Free shipping Free shipping. Stratagene MxP Multiplex Quantitative Real Time PCR System. Agilent ChemStation for CE Systems Installation Guide User Manual. Pre-owned Pre-owned Pre-owned. $ $ previous price $ 20% off 20% off previous Seller Rating: % positive. Stratagene QPCR Instruments and Reagents from Agilent Technologies With the addition of Stratagene real-time PCR solutions, Agilent offers the most comprehensive workflow solution for gene expression analysis. The MxP system is a flexible real-time PCR instrument suited for gene expression analy-.
The MxPro qPCR Software, for the MxP and MxP qPCR Systems, combines robust data analysis algorithms with simple organization features, designed for the ultimate ease of use. The MxP and MxP qPCR systems have now been replaced by the AriaMx qPCR System. Support is available until Decem. For Research Use Only. Stratagene QPCR Instruments and Reagents from Agilent Technologies With the addition of Stratagene real-time PCR solutions, Agilent offers the most comprehensive workflow solution for gene expression analysis. The MxP system is a flexible real-time PCR instrument suited for gene expression analy-. 30 nM Stratagene MxP, MxP and Mx systems; ABI system ROX reference dye is included in the master mix to compensate for non-PCR related variations in fluorescence. Fluorescence from ROX dye does not change during the course of the PCR reaction but provides a stable baseline to which samples are normalized.
refer to your qPCR instrument manual (optional) Stratagene, MXP, MXP and MX are trademarks of Agilent Technologies, Inc. Mastercycler® ep realplex models 2, 2S, 4, 4S; Agilent (Stratagene) models MxP®, MxP®; Takara TP t Suitable for use with the following. Protocol. Agilent Technologies. 1. Before You Begin. Materials Provided 8 If using the Stratagene MxP or MxP QPCR system or the ABI.
0コメント